This case study outlines the decision-making process a new Aluris client used to determine the best cGMP manufacturing solution for their applied market NGS kits. Faced with the need to quickly scale, their options were to expand internal manufacturing capabilities or outsource. Ultimately, outsourcing was chosen, as it had the lowest risk to the company and was their fastest route to market. Their primary concern over costs was overcome by engaging the Aluris Ecosystem. Rather than retaining pieces of the manufacturing path internally, a turnkey solution was chosen to maintain company focus.
Read this case study to learn more about strategic outsourcing in biotech.
